Displaying drugs 1851 - 1875 of 2774 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Darolutamide | 398.85 C19H19ClN6O2 |  | An androgen receptor antagonist used for castration-resistant, non-metastatic prostate cancer and metastatic hormone-sensitive prostate cancer. | Antiandrogens |
| Colchicine | 399.443 C22H25NO6 |  | An alkaloid used to treat gout and Familial Mediterranean Fever as well as prevent major cardiovascular events. | Preparations With No Effect on Uric Acid Metabolism |
| Thiethylperazine | 399.616 C22H29N3S2 |  | A drug used for the treatment of nausea and vomiting. | Phenothiazine Derivatives |
| Prednisone acetate | 400.471 C23H28O6 |  | Not Annotated | Anti-Inflammatory Agents / Antineoplastic Agents, Hormonal / Corticosteroids / Glucocorticoids / Pregnadienediols |
| Testosterone enanthate | 400.594 C26H40O3 |  | An androgen used to treat low or absent testosterone. | Androgens |
| Prasterone enantate | 400.603 C26H40O3 |  | An estrogen indicated for hormone replacement therapy in postmenopausal women. | 17-Ketosteroids / Adrenal Cortex Hormones / Androstanes / Androstenes / Androstenols / Fused-Ring Compounds / Gonadal Hormones / Gonadal Steroid Hormones / Hormones / Hormones, Hormone Substitutes, and Hormone Antagonists / Ketosteroids / Steroids / Testosterone Congeners |
| Calcifediol | 400.6371 C27H44O2 |  | An active metabolite of vitamin D used to treat hyperparathyroidism as well as to combat hypocalcemia in dialysis patients. | Vitamins |
| Alfacalcidol | 400.6371 C27H44O2 |  | A vitamin D analogue used for the management of hypocalcemia, secondary hyperparathyroidism, and osteodystrophy in patients with chronic renal failure, as well as some types of rickets and osteomalacia. | Bone Density Conservation Agents / Vitamin D and Analogues |
| Zuclopenthixol | 400.965 C22H25ClN2OS |  | An antipsychotic indicated for the management of schizophrenia. The acuphase formulation is indicated for initial treatment of acute psychosis or exacerbation of psychosis, while the depot formulation is best for maintenance. | Thioxanthene Derivatives |
| Oxyphenisatin acetate | 401.418 C24H19NO5 |  | Oxyphenisatin acetate is the pro-drug of oxyphenisatin (3,3-bis(4-hydroxyphenyl)-1H-indol-2-one). The FDA withdrew its approval for the use of oxyphenisatin acetate due to safety reasons. | Indoles / Laxatives |
| Moxifloxacin | 401.4314 C21H24FN3O4 |  | A fluoroquinolone antibiotic used to treat various bacterial infections. | Fluoroquinolones |
| Oxacillin | 401.436 C19H19N3O5S |  | A penicillin antibiotic used to treat a number of susceptible bacterial infections. | Beta-Lactamase Resistant Penicillins |
| Risdiplam | 401.474 C22H23N7O |  | An oral mRNA splicing modifier used in the treatment of spinal muscular atrophy (SMA). | BCRP/ABCG2 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A7 Substrates / Cytochrome P-450 Substrates / MATE 1 Inhibitors / MATE 2 Inhibitors / MATE inhibitors / Musculo-Skeletal System / Other Miscellaneous Therapeutic Agents / P-glycoprotein substrates / Peripheral Nervous System Agents / Survival Motor Neuron-2-directed RNA Interaction / Survival of Motor Neuron 2 Splicing Modifier |
| Cortisone acetate | 402.4807 C23H30O6 |  | A steroid hormone used for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and endocrine disorders associated with inadequate production of steroid hormones. | Anti-Inflammatory Agents / Glucocorticoids |
| Prednisolone acetate | 402.4807 C23H30O6 |  | A glucocorticoid used to treat a wide variety of endocrine, inflammatory, and immune conditions as well as for palliation of neoplastic conditions. | Anti-Inflammatory Agents / Prodrugs |
| Clascoterone | 402.531 C24H34O5 |  | An androgen receptor antagonist used for the topical treatment of acne vulgaris in patients 12 years of age and older. | Androgen Receptor Inhibitors |
| Dehydrocholic acid | 402.531 C24H34O5 |  | No approved therapeutic indications. | Cholagogues and Choleretics / Cholic Acids |
| Roflumilast | 403.207 C17H14Cl2F2N2O3 |  | A selective phosphodiesterase-4 inhibitor indicated to decrease the risk of exacerbations in patients with severe chronic obstructive pulmonary disease (COPD) and to treat plaque psoriasis. | Phosphodiesterase 4 Inhibitors |
| Phthalylsulfathiazole | 403.43 C17H13N3O5S2 |  | A sulfonamide antibacterial indicated in the treatment of gastrointestinal infections. | Sulfonamides |
| Benzhydrocodone | 403.478 C25H25NO4 |  | Benzyhydrocodone is indicated, in combination with acetaminophen, for the short-term management of acute pain requiring opioid therapy. | Opioids |
| Metergoline | 403.526 C25H29N3O2 |  | An ergot-derivative that acts as an antagonist at certain 5-HT receptor subtypes and as an agonist at dopamine receptors. It is often used in situations where inhibition of prolactin is desirable. | Prolactine Inhibitors |
| Perphenazine | 403.969 C21H26ClN3OS |  | A phenothiazine used to treat schizophrenia as well as nausea and vomiting. | Phenothiazines With Piperazine Structure |
| Lesinurad | 404.28 C17H14BrN3O2S |  | A uric acid 1 transporter inhibitor typically used in combination with a xanthine oxidase inhibitor to treat hyperuricemia associated with gout in patients with inadequate control of uric acid levels with xanthine oxidase inhibitor monotherapy. | Preparations Increasing Uric Acid Excretion |
| Ozanimod | 404.47 C23H24N4O3 |  | A sphingosine 1-phosphate receptor modulator being studied to treat Multiple Sclerosis (MS) and inflammatory bowel disease (IBD). | Selective Immunosuppressants |
| Sulfinpyrazone | 404.482 C23H20N2O3S |  | A platelet inhibitory and uricosuric agent used to inhibit thrombotic and embolic processes and to manage the chronic phases of gout . | Preparations Increasing Uric Acid Excretion |
Displaying drugs 1851 - 1875 of 2774 in total